0001193125-15-009223.txt : 20150113 0001193125-15-009223.hdr.sgml : 20150113 20150113142329 ACCESSION NUMBER: 0001193125-15-009223 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150113 DATE AS OF CHANGE: 20150113 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Nuo Therapeutics, Inc. CENTRAL INDEX KEY: 0001091596 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 232958959 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62061 FILM NUMBER: 15524496 BUSINESS ADDRESS: STREET 1: 207A PERRY PARKWAY, STREET 2: SUITE 1 CITY: GAITHERSBURG, STATE: MD ZIP: 20877 BUSINESS PHONE: 240-499-2680 MAIL ADDRESS: STREET 1: 207A PERRY PARKWAY, STREET 2: SUITE 1 CITY: GAITHERSBURG, STATE: MD ZIP: 20877 FORMER COMPANY: FORMER CONFORMED NAME: Nuo Therapeutics, Inc DATE OF NAME CHANGE: 20141112 FORMER COMPANY: FORMER CONFORMED NAME: CYTOMEDIX INC DATE OF NAME CHANGE: 20000511 FORMER COMPANY: FORMER CONFORMED NAME: AUTOLOGOUS WOUND THERAPY INC DATE OF NAME CHANGE: 20000407 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: SHEEDY CHARLES E CENTRAL INDEX KEY: 0001005483 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: TWO HOUSTON CENTER STREET 2: SUITE 2907 CITY: HOUSTON STATE: TX ZIP: 77010 SC 13G/A 1 d851686dsc13ga.htm SC 13G/A SC 13G/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 4)*

 

 

NUO THERAPEUTICS, INC.

(Name of Issuer)

Common stock, par value $.0001 per share

(Title of Class of Securities)

23283B204

(CUSIP Number)

December 31, 2014

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Continued on following pages

Page 1 of 5 Pages

 

 

 


CUSIP No. 23283B204   Page 2 of 5 Pages

 

  1   

Names of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only)

 

Charles E. Sheedy

  2  

Check the Appropriate Box If a Member of a Group (See Instructions)

 

a.  ¨

b.  ¨

  3  

SEC Use Only

 

  4  

Citizenship or Place of Organization

 

UNITED STATES

Number of

Shares

Beneficially

Owned By

Each

Reporting

Person

With

     

Sole Voting Power

 

8,288,247

   6   

Shared Voting Power

 

0

   7   

Sole Dispositive Power

 

8,288,247

   8   

Shared Dispositive Power

 

0

  9  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

8,288,247

10  

Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

¨

11  

Percent of Class Represented By Amount in Row (9)

 

6.7%

12  

Type of Reporting Person (See Instructions)

 

IN

 


CUSIP No. 23283B204   Page 3 of 5 Pages

 

Item 1(a) Name of Issuer:

Nuo Therapeutics, Inc. (the “Issuer”).

 

Item 1(b) Address of the Issuer’s Principal Executive Offices:

209 Perry Parkway, Suite 1

Gaithersburg, MD 20877

 

Item 2(a) Name of Person Filing:

This statement is filed on behalf of Charles E. Sheedy (the “Reporting Person”).

 

Item 2(b) Address of Principal Business Office or, if None, Residence:

Two Houston Center, Suite 2907

909 Fannin Street

Houston, TX 77010

 

Item 2(c) Citizenship:

The Reporting Person is a citizen of the United States.

 

Item 2(d) Title of Class of Securities:

Common stock, 0.0001 par value (the “Shares”).

 

Item 2(e) CUSIP Number:

23283B204

 

Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

The person filing is not listed in Items 3(a) through 3(k).

 

Item 4. Ownership:

 

Item 4(a) Amount Beneficially Owned:

As of the date hereof, the Reporting Person may be deemed to be the beneficial owner of 8,288,247 Shares. This number consists of: (i) 6,689,652 Shares held by the Reporting Person and (ii) 1,598,595 Shares issuable upon exercise of a warrant held by the Reporting Person.

 

Item 4(b) Percent of Class:

According to the Issuer’s Form 10-Q filed with the Securities and Exchange Commission November 13, 2014, the number of Shares outstanding as of November 6, 2014 was 124,410,100. Assuming exercise of the warrant held by the Reporting Person, the Reporting Person may be deemed to be the beneficial owner of approximately 6.7% of the total number of Shares outstanding.


CUSIP No. 23283B204   Page 4 of 5 Pages

 

Item 4(c) Number of shares as to which such person has:

 

Sheedy, Charles E.

(i)

   Sole power to vote or direct the vote    8,288,247

(ii)

   Shared power to vote or to direct the vote    0

(iii)

   Sole power to dispose or to direct the disposition of    8,288,247

(iv)

   Shared power to dispose or to direct the disposition of    0

 

Item 5. Ownership of Five Percent or Less of a Class:

This Item 5 is not applicable.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person:

This Item 6 is not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

This Item 7 is not applicable.

 

Item 8. Identification and Classification of Members of the Group:

This Item 8 is not applicable.

 

Item 9. Notice of Dissolution of Group:

This Item 9 is not applicable.

 

Item 10. Certification:

By signing below the Reporting Person certifies that, to the best of such person’s knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.


CUSIP No. 23283B204   Page 5 of 5 Pages

 

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

Date: January 13, 2015     Charles E. Sheedy
     

/s/ Charles E. Sheedy